NEWS: No extension of EU license for glyphosate
Published 10 Jun 2016
The European Commission has failed to secure an extension of the licence for the controversial pesticide glyphosate.
The Commission had asked member states to back the extension of the license for 18 months, until after the European Chemicals Agency (ECHA) publishes its report on the health risks of glyphosate, which is due in 2017. However, several key member states either voted against the extension of the licence or abstained, meaning that the Commission could not secure the qualified majority it needed.
Breast Cancer UK has previously urged UK representatives to vote against any proposals to authorise the sale of glyphosate due to our concerns that the pesticide acts as an oestrogen mimic and could have the potential to adversely affect breast development. The International Agency for Research on Cancer also concluded that glyphosate is probably carcinogenic to humans.
A committee of member states has twice refused to back the renewal of the license for glyphosate. Unless the Commission can secure an extension of the licence ahead of a 30th June deadline, products containing glyphosate could be withdrawn from the EU market.
The European Commission will now take the matter to an appeal committee. We have joined forces with other NGOs to call on the Commission to recognise the risks posed by glyphosate and put the health of European citizens first.
You can find out more about glyphosate by reading our science briefing.